Thermo Fisher Scientific (TMO) Enterprise Value (2009 - 2026)

Thermo Fisher Scientific has disclosed Enterprise Value across 18 years of filings, most recently posting -$3.2 billion for Q1 2026.

• Quarterly Enterprise Value rose 44.17% year-over-year to -$3.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.2 billion (up 44.17% YoY) and the FY2025 annual result came in at -$10.1 billion, down 85.28% from the prior year.
• Enterprise Value rose to -$3.2 billion in Q1 2026, from -$10.1 billion in the prior quarter.
• Over five years, Enterprise Value peaked at -$1.8 billion in Q3 2022 and troughed at -$10.1 billion in Q4 2025.
• A 5-year average of -$5.4 billion and a median of -$5.8 billion in 2025 frame the typical range for Enterprise Value.
• Annual changes were most pronounced in 2022 — Enterprise Value soared 76.72% — and 2024, when it plunged 188.34%.
• Tracing TMO's Enterprise Value over 5 years: stood at -$8.4 billion in 2022, then climbed by 5.3% to -$8.0 billion in 2023, then surged by 31.55% to -$5.4 billion in 2024, then plunged by 85.28% to -$10.1 billion in 2025, then soared by 67.83% to -$3.2 billion in 2026.
• Business Quant data shows TMO's Enterprise Value at -$3.2 billion in Q1 2026, -$10.1 billion in Q4 2025, and -$3.4 billion in Q3 2025.